Description
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Cas No. | 1096708-71-2 |
|---|---|
| Purity | ≥98% |
| Formula | C17H12Cl2F3N7O2S |
| Formula Wt. | 506.30 |
| IUPAC Name | 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5- chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide |
| Solubility | DMSO 100 mg/mL (197.51 mM) Ethanol 100 mg/mL (197.51 mM) Water Insoluble |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
http://clinicaltrials.gov/show/NCT01425008
Synthetic ITC.
NSAID; COX-1/2 inhibitor.
Alkaloid found in Sophora.
Ansamycin; bacterial DNA-dependent RNA polymera...
JAK1 inhibitor.
Naphthalene; indirect STAT1 agonist.
Histamine H2 antagonist.
ACE inhibitor.
Fluoroquinolone; bacterial DNA gyrase inhibitor...
Thiazolidinedione; PPARγ agonist.
Aspirin analog; hemoglobin chain cross-linker.<...
BRD inhibitor.
Neuropeptide found in crustaceans and insects.<...
β-adrenergic antagonist, Kv1.4 and K2P2 K+ cha...
Caffeic acid ester found in Melissa, Salvia, an...
Imidazole; 14-α demethylase inhibitor.
Endogenous bile acid; FXR agonist.
Synthesis impurity
BH3 mimetic; Bcl-2 and Bcl-xl inhibitor.